Type | All patients (n = 93) | IDH | Control | |
Antihypertensive treatment | 59 (63.4%) | 17 (81%) | 42 (58.3%) | |
ICE | 37 (39.8%) | 10 (55.6%) | 27 (55.1%) | |
AAR | 7 (11.3%) | 3 (17.6%) | 4 (8.9%) | |
ICC | 41 (66.1%) | 13 (76.5%) | 28 (62.2%) | |
Beta-blockers | 16 (25.8%) | 5 (29.4%) | 11 (24.4%) | |
Number of molecules (mean) | 1.98 ± 1.06 | 2.06 ± 1.25 | 1.95 ± 0.99 | |